Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia
Authors:
- 1 August 2017
- journal article
- review article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 78, 1-11
Abstract
No abstract availableKeywords
This publication has 127 references indexed in Scilit:
- Fatty acid consumption and the risk of osteoporotic fracture2013
- Vitamin D Inflammatory Cytokines and Coronary Events: A Comprehensive ReviewClinical Reviews in Allergy & Immunology, 2013
- The Oxidative Stress May be Induced by the Elevated Homocysteine in Schizophrenic PatientsNeurochemical Research, 2012
- Elevated plasma superoxide dismutase in first-episode and drug naive patients with schizophrenia: Inverse association with positive symptomsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2012
- Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychoticsNeuroscience Letters, 2010
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Oxidative stress, α-tocopherol, ascorbic acid and reduced glutathione status in schizophrenicsIndian Journal of Clinical Biochemistry, 2006
- Resurrection of vitamin D deficiency and ricketsJournal of Clinical Investigation, 2006
- The TNF alpha converting enzyme (TACE/ADAM17) is expressed in the atherosclerotic lesions of apolipoprotein E-deficient mice: Possible contribution to elevated plasma levels of soluble TNF alpha receptorsAtherosclerosis, 2006
- Free radical-mediated oxidation of free amino acids and amino acid residues in proteinsAmino Acids, 2003